Aphria Inc (NYSE:APHA) shares gapped up prior to trading on Friday . The stock had previously closed at $3.81, but opened at $4.16. Aphria shares last traded at $4.31, with a volume of 7,038,896 shares trading hands.
A number of brokerages have weighed in on APHA. Cantor Fitzgerald initiated coverage on Aphria in a research note on Tuesday, November 5th. They set an “overweight” rating and a $10.40 price target on the stock. Jefferies Financial Group reaffirmed a “buy” rating and issued a $10.30 price objective on shares of Aphria in a research report on Monday, January 20th. ValuEngine lowered Aphria from a “buy” rating to a “hold” rating in a research note on Thursday, December 5th. Alliance Global Partners began coverage on Aphria in a research note on Tuesday, January 21st. They issued a “buy” rating and a $11.00 target price for the company. Finally, Zacks Investment Research downgraded Aphria from a “strong-buy” rating to a “hold” rating in a research report on Monday, January 6th. Four analysts have rated the stock with a hold rating and six have assigned a buy rating to the stock. The company currently has an average rating of “Buy” and a consensus target price of $11.84.
The business’s fifty day moving average is $4.88 and its 200-day moving average is $5.37. The stock has a market capitalization of $1.09 billion, a PE ratio of -17.24 and a beta of 2.79.
Aphria Company Profile (NYSE:APHA)
Aphria Inc produces and sells medical cannabis in Canada and internationally. The company offers sativa, indica, and hybrid medical marijuana products, as well as cannabis oils. It serves patients and health professionals. The company also sells its products online. Aphria Inc is headquartered in Leamington, Canada.
See Also: How to identify percentage decliners
Receive News & Ratings for Aphria Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aphria and related companies with MarketBeat.com's FREE daily email newsletter.